SD HEALTHCARE
Recent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Ex-Illumina Leaders Form Own Cos. To Pursue Genomics Work
Kevin Gunderson was employee No. 7 of 6,000 at Illumina. He led the company’s advanced research group for almost 18 years, helping create its first $1 billion product line.
Illumina’s Progress Creates Encouraging Ecosystem for Others
Ex-Illumina Leaders Form Own Cos. To Pursue Genomics Work
In 2000, the cost to sequence a genome stood at $100 million.
ViaCyte Set to Receive $15M in Diabetes Collaboration
ViaCyte, a San Diego stem cell therapy biotech, has teamed up with a Massachusetts gene-editing company to take on diseases like diabetes.
Sherpa Clinical Packaging Acquired
San Diego-based Sherpa Clinical Packaging has been acquired by PCI Pharma Services under a deal announced Sept. 11 in which terms were not disclosed.
Vital Therapies Abandons Liver Treatment After Clinical Trial
San Diego’s Vital Therapies on Sept. 12 scrapped a cell-based therapy intended to treat acute liver failure following final-stage clinical trials, sending the company’s stock plummeting.
Epic Sciences Pulls in $52M Series E Round
Epic Sciences on Sept. 12 hauled in a $52 million Series E round to advance a portfolio of tests.
Exagen Diagnostics Launches Blood Test for Managing Rheumatoid Arthritis
Vista-based Exagen Diagnostics launched a blood test for added insight in managing rheumatoid arthritis.
Ramping up its Commercial Strategy, Halozyme Hires a CCO
Halozyme Therapeutics hired pharmaceutical veteran Benjamin Hickey as the company’s chief commercial officer, it was recently announced.
Sharp Blames Actions By Agency for Its Exit of Accountable Care Organization
HEALTH: Sharp Says Moves By CMS Changed Savings to a Loss
Sharp HealthCare is considering its legal options after earlier this year withdrawing from a Medicare program in which health systems shoulder greater accountability.
ResMed Files Lawsuit Over Alleged Patent Infringements
A patent dispute between ResMed and Fisher & Paykel Healthcare has escalated.
$65 Million Pledged for UCSD Drug Development Partnership
A New York investment management firm has pledged $65 million to a new venture with UC San Diego to bridge the divide between basic research and clinical trials.
Gary and Mary West Foundation Helps Establish Not-For-Profit Generic Drug Co.
San Diego’s Gary and Mary West Foundation is helping get off the ground Civica RX, a new not-for-profit generic drug company with the goal of tackling shortages and high prices on life-saving medications.
Gossamer Lures Former Bristol-Myers Squibb Executive as CSO
San Diego-based Gossamer Bio, which in July snagged a $230 million series B round, recently announced the hire of a former executive from pharmaceutical giant Bristol-Myers Squibb.
Life Sciences Reporter's Notebook: Some Biotechs Find Freedom in Self-Commercialization Model
Not many biotechs in San Diego both develop drugs and commercialize them.
$65M Pledged for Drug Development Partnership with UC San Diego
A New York investment management firm has pledged $65 million to a new venture with UC San Diego to bridge the divide between basic research and clinical trials.
Prev Next